ÂÜÀòÂÒÂ×

Michael co-founded and leads Fio Corporation, which pioneered and commercialized a data-and-device platform that brings to community-based healthcare settings below the level of hospitals the same level of quality in diagnostics, treatment, and tracking that is currently available mostly in hospitals. This platform – Fionet – comprises mobile devices that provide quality-controlled diagnosis and treatment guidance at the point of care, integrated with real-time tracking and reporting for remote supervisors, managers, public health agencies, and funders. Previously, Michael built a global champion in medical imaging software: one billion medical imaging patient scans were performed worldwide with this technology. He led that company from startup to a public offering on NASDAQ and the Toronto Stock Exchange, the Profit 100 list, the top-performing stock on the Toronto Stock Exchange, winning the Canada Export Award, and the Canada Award for Business Excellence in Innovation. Eighteen months after Michael left the company, it was sold in a deal worth 500 million dollars, and later acquired by IBM. Michael received a medical degree from the University of Pennsylvania and went on to a neurosurgery residency and a National Institutes of Health biophysics post-doctoral fellowship at the University of Toronto.